Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Express Scripts
Medtronic
Merck
Mallinckrodt

Last Updated: September 24, 2022

Details for New Drug Application (NDA): 021545


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 021545 describes PATADAY ONCE DAILY RELIEF, which is a drug marketed by Alcon Labs Inc and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug. Additional details are available on the PATADAY ONCE DAILY RELIEF profile page.

The generic ingredient in PATADAY ONCE DAILY RELIEF is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 021545
Tradename:PATADAY ONCE DAILY RELIEF
Applicant:Alcon Labs Inc
Ingredient:olopatadine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021545
Suppliers and Packaging for NDA: 021545
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PATADAY ONCE DAILY RELIEF olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545 NDA Alcon Laboratories, Inc. 0065-8150 0065-8150-01 1 BOTTLE, PLASTIC in 1 CARTON (0065-8150-01) > 2.5 mL in 1 BOTTLE, PLASTIC
PATADAY ONCE DAILY RELIEF olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545 NDA Alcon Laboratories, Inc. 0065-8150 0065-8150-03 2 BOTTLE, PLASTIC in 1 CARTON (0065-8150-03) > 2.5 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.2% BASE
Approval Date:Dec 22, 2004TE:RLD:Yes

Expired US Patents for NDA 021545

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Labs Inc PATADAY ONCE DAILY RELIEF olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545-001 Dec 22, 2004 See Plans and Pricing See Plans and Pricing
Alcon Labs Inc PATADAY ONCE DAILY RELIEF olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545-001 Dec 22, 2004 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKinsey
McKesson
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.